Loading...
 
Mediterr J Rheumatol 2019;30(2):94-102
Vitamin D Deficiency and Rheumatoid Arthritis: Epidemiological, Immunological, Clinical and Therapeutic Aspects
Authors Information

1Mobility Impairment Research Center; 2Clinical Research Development Unit of Rouhani Hospital; 3Department of Internal Medicine, Division of Rheumatology; 4Department of Statistics and Epidemiology, School of Medicine; Babol University of Medical Sciences, Babol, Islamic Republic of Iran

References
  1. Haq A, Svobodová J, Imran S, Stanford C, Razzaque MS5. Vitamin D deficiency: A single centre analysis of patients from 136 countries. J Steroid Biochem Mol Biol 2016;164:209-13. [https://doi.org/10.1016/j.jsbmb.2016.02.007] [PMID: 26877203]
  2. Cutolo M. Vitamin D and autoimmune rheumatic diseases. Rheumatology 2009;48:210-2. [https://doi.org/10.1093/rheumatology/ken394] [PMID: 18930963]
  3. Hossein-nezhad A, Holich MF. Vitamin D for health: A global perspective. Mayo Clin Proc 2013; 88(7):720-75. [https://doi.org/10.1016/j.mayocp.2013.05.011] [PMID: 23790560] [PMCID: PMC3761874]
  4. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr 2014; 14;111(1):23-45. [https://doi.org/10.1017/S0007114513001840] [PMID: 23930771]
  5. Haroon M, Bond U, Quillinan N, Phelan MJ, Regan MJ. The prevalence of vitamin D deficiency in consecutive new patients seen over a 6-month period in general rheumatology clinics. Clin Rheumatol 2011;30(6):789-94. [https://doi.org/10.1007/s10067-010-1659-0] [PMID: 21184246]
  6. Heidari B, Heidari P, Tilaki KH. High Prevalence of Vitamin D Deficiency in Women Presenting to Rheumatology Clinic in North of Iran: An Inverse Relation with Age. J Women’s Health Care 2013; 2:123. [https://doi.org/10.4172/2167-0420.1000123]
  7. Zheng ZH, Gao CC, Wu ZZ, Liu SY, Li TF, Gao GM, et al. High prevalence of hypovitaminosis D of patients with autoimmune rheumatic diseases in China. J Clin Exp Immunol 2016;5(3):48-54. [PMID: 27335701] [PMCID: PMC4913223]
  8. Jeffery LE, Raza K, Hewison M. Vitamin D in rheumatoid arthritis-towards clinical application. Nat Rev Rheumatol 2016;12(4):201-10. [https://doi.org/10.1038/nrrheum.2015.140] [PMID: 26481434]
  9. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007;66(9):1137-42. [https://doi.org/10.1136/ard.2007.069831] [PMID: 17557889] [PMCID: PMC1955167]
  10. Gatenby P, Lucas R, Swaminathan A. Vitamin D deficiency and risk for rheumaticn diseases: an update. Curr Opin Rheumatol 2013;25(2):184-91. [https://doi.org/10.1097/BOR.0b013e32835cfc16] [PMID: 23370372]
  11. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 2004;229:1136-42. [PMID: 15564440]
  12. Cutolo M. Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther 2008;10(6):123. [https://doi.org/10.1186/ar2552] [PMID: 19090978] [PMCID: PMC2656237]
  13. Dankers W, Colin EM, van Hamburg JP, Lubberts E. (2017) Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol 7:697. [https://doi.org/10.3389/fimmu.2016.00697] [PMID: 28163705] [PMCID: PMC5247472]
  14. Hossein-nezhad A, Holick MF. Optimize dietary intake of vitamin D: an epigenetic perspective. Curr Opin Clin Nutr Metab Care 2012;15(6):567-79. [https://doi.org/10.1097/MCO.0b013e3283594978] [PMID: 23075936]
  15. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84(1):18-28. [https://doi.org/10.1093/ajcn/84.1.18] [PMID: 16825677]
  16. Colotta F, Jansson B, Bonelli F. Modulation of inflammatory and immune responses by vitamin D. Autoimmun 2017;85:79-97. [https://doi.org/10.1016/j.jaut.2017.07.007 ] [PMID: 28733125]
  17. Zhang Y, Leung DYM, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase. J Immunol 2012;188(5):2127-35. [https://doi.org/10.4049/jimmunol.1102412]
  18. Peterlik M, Cross HS. Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and chronic diseases. Anticancer Res 2006;26:2581-8.
  19. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009;361:888-98. [https://doi.org/10.1056/NEJMra0707449] [PMID: 19710487]
  20. Boissier MC, Assier E, Falgarone G, Bessis N. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 2008;75(4):373-5. [https://doi.org/10.1016/j.jbspin.2008.04.005] [PMID: 18571969]
  21. Serrano Hernández A. [Helper (TH1, TH2, TH17) and regulatory cells (Treg, TH3, NKT) in rheumatoid arthritis]. Reumatol Clin 2009;5 Suppl 1:1-5. [https://doi.org/10.1016/j.reuma.2008.11.012] [PMID: 21794634]
  22. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93–101. [https://doi.org/10.1016/j.jsbmb.2005.06.002] [PMID: 16046118]
  23. Ranganathan P, Khalatbari S, Yalavarthi S, Marder W, Brook R, Kaplan MJ. Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis. Rheumatol 2013;40(9):1529-34. [https://doi.org/10.3899/jrheum.130012] [PMID: 23818717] [PMCID: PMC4358878]
  24. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000 Mar;223(3):230-3. [PMID: 10719834]
  25. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review the literature. Autoimmun Rev 2012;12(2):127-36. [https://doi.org/10.1016/j.autrev.2012.07.007] [PMID: 22776787]
  26. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 2004;50(1):72-7. [https://doi.org/10.1002/art.11434] [PMID: 14730601]
  27. Song GG, Bae SC, Lee YH. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol. 2012;31(12):1733-9. [https://doi.org/10.1007/s10067-012-2080-7] [PMID: 22941259]
  28. Franco AS, Freitas TQ, Bernardo WM, Pereira RMR. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96(23):e7024. [https://doi.org/10.1097/MD.0000000000007024] [PMID: 28591033] [PMCID: PMC5466211]
  29. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008;67(4):530-5. [https://doi.org/10.1136/ard.2007.072736] [PMID: 17666449] [PMCID: PMC2717608]
  30. Hiraki LT, Munger KL, Costenbader KH, Karlson EW. Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64(12):1829-36. [https://doi.org/10.1002/acr.21776] [PMID: 22744978] [PMCID: PMC3488139]
  31. Feser M, Derber LA, Deane KD, Lezotte DC, Weisman MH, Buckner JH, et al. Plasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA. J Rheumatol 2009;36(5):943-6. [https://doi.org/10.3899/jrheum.080764] [PMID: 19286844] [PMCID: PMC2745328]
  32. Nielen MM, van Schaaredenburg D, Lems WF, van Stadt RJ, de Koning M, Reesink HW, Habibuw MR. Vitamin D deficiency does not increase the risk of rheumatoid arthritis. Arthritis Rheum 2006,54:3719-20. [https://doi.org/10.1002/art.22191] [PMID: 17075887]
  33. Lee TH, Jin WS, Park J, Choi HH, Bae EJ. Vitamin D status and its associations with rheumatoid arthritis in Korean women: the Korean National Health and Nutrition Examination Survey 2008-2014. Exerc Rehabil 2016;12(6):610-7. [https://doi.org/10.12965/jer.1632870.435] [PMID: 28119885] [PMCID: PMC5227325] 
  34. Bragazzi NL, Wagtad A, Neumann SG, Simon M, Brown SB, Abu Much A, et al. Vitamin D and rheumatoid arthritis: an ongoing mystery. Curr Opin Rheumatol 2017;29(4):378-88. [https://doi.org/10.1097/BOR.0000000000000397] [PMID: 28463872]
  35. Di Franco M, Barchetta I, Iannuccelli C, Gerardi MC, Frisenda S, Ceccarelli F, et al. Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study. BMC Musculoskelet Disord 2015;16:53. [https://doi.org/10.1186/s12891-015-0505-6] [PMID: 25887374] [PMCID: PMC4373034]
  36. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007;56(7):2143-9. [https://doi.org/10.1002/art.22722] [PMID: 17599737]
  37. Lee YH, Bae SC. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol 2016;34(5):827-33. [PMID: 27049238]
  38. Kostoglou-Athanassiou I, Athanassiou P, L. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab 2012;3(6):181-7. [https://doi.org/10.1177/2F2042018812471070]
  39. Moghimi J, Sadeghi A, Malek M, Ghorbani R. Relationship between disease activity and serum levels of vitamin D and parathyroid hormone in rheumatoid arthritis. Endocr Regul 2012;46(2):61-6. [PMID: 22540853]
  40. Quintana-Duque MA, Caminos JE, Varela-Nariño A, Calvo-Paramo E, Yunis JJ, Iglesias-Gamarra A. The Role of 25-Hydroxyvitamin D as a Predictor of Clinical and Radiological Outcomes in Early Onset Rheumatoid Arthritis. Clin Rheumatol 2017;23(1):33-39. [https://doi.org/10.1097/RHU.0000000000000477] [PMID: 28002154]
  41. Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir AM, Balbir-Guman A. Vitamin D level: is it related to disease activity in inflammatory joint disease? Rheumatol Int 2011;31(4):493-9. [https://doi.org/10.1007/s00296-009-1251-6] [PMID: 20033415]
  42. Rossini M, Maddali Bongi S, La Montagna G, Minisola G, Malavolta N, Bernini L, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010;12(6):R216. [https://doi.org/10.1186/ar3195] [PMID: 21114806] [PMCID: PMC3046526]
  43. Raczkiewicz A, Kisiel B, Kulig M, Tłustochowicz W. Vitamin D status and its association with quality of life, physical activity, and disease activity in rheumatoid arthritis patients. J Clin Rheumatol 2015;21(3):126-30. [https://doi.org/10.1097/RHU.0000000000000233] [PMID: 25807091]
  44. Zakeri Z, Sandoughi M, Mashhadi MA, Raeesi V, Shahbakhsh S. Serum vitamin D level and disease activity in patients with recent onset rheumatoid arthritis. Int J Rheum Dis 2016;19(4):343-7. [https://doi.org/10.1111/1756-185X.12181] [PMID: 24134402]
  45. Hong Q, Xu J, Xu S, Lian L, Zhang M, Ding C. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatology (Oxford) 2014;53(11):1994-2001. [https://doi.org/10.1093/rheumatology/keu173] [PMID: 24907153]
  46. Abourazzak F, Talbi S, Aradoini N, Berrada K, Keita S, Hazry T. 25-Hydroxy vitamin D and its relationship with clinical and laboratory parameters in patients with rheumatoid arthritis. Clin Rheumatol 2015;34(2):353-7. [https://doi.org/10.1007/s10067-014-2713-0] [PMID: 24924607]
  47. Lin J, Liu J, Davies ML, Chen W. Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis. PLoS One 2016;11(1):e0146351. [https://doi.org/10.1371/journal.pone.0146351] [PMID: 26751969] [PMCID: PMC4709104]
  48. Vojinovic J, Tincani A, Sulli A, Soldano S, Andreoli L, Dall'Ara F, et al.European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). Autoimmun Rev 2017;16(5):548-54. [https://doi.org/10.1016/j.autrev.2017.03.002] [PMID: 28279841]
  49. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035. [https://doi.org/10.1136/bmj.g2035] [PMID: 24690624] [PMCID: PMC3972415]
  50. Pakchotanon R, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P. The association between serum vitamin D Level and disease activity in Thai rheumatoid arthritis patients. Int J Rheum Dis 2016;19(4):355-61. [https://doi.org/10.1111/1756-185X.12222] [PMID: 24219063]
  51. Haque UJ, Bartlett SJ. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 2010;28(5):745-7. [PMID: 20883640]
  52. Baykal T, Senel K, Alp F, Erdal A, Ugur M. Is there an association between serum 25-hydroxyvitamin D concentrations and disease activity in rheumatoid arthritis? Bratisl Lek Listy 2012;113(10):610-1. [PMID: 23094901]
  53. Rajaee E, Ghorbani A, Mowla K, Zakerkish M, Mohebi M, Dargahi-Malamir M. The Relationship between Serum Level of Vitamin D3 and the Severity of New Onset Rheumatoid Arthritis Activity. Clin Diagn Res 2017;11(3):OC28-OC30. [https://doi.org/10.7860/JCDR/2017/24014.9486] [PMID: 28511431] [PMCID: PMC5427357]
  54. Matsumoto Y, Sugioka Y, Tada M, Okano T, Mamoto K, Inui K, et al. Relationships between serum 25-hydroxycalciferol, vitamin D intake and disease activity in patients with rheumatoid arthritis--TOMORROW study. Mod Rheumatol 2015;25(2):246-50.  [https://doi.org/10.3109/14397595.2014.952487] [PMID: 25211403]
  55. Baker JF, Baker DG, Toedter G, Shults J, Von Feldt JM, Leonard MB. Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol 2012;30(5):658-64. [PMID: 22776409]
  56. Haga HJ, Schmedes A, Naderi Y, Moreno AM, Peen E. Severe deficiency of 25-hydroxyvitamin D₃ (25-OH-D₃) is associated with high disease activity of rheumatoid arthritis. Clin Rheumatol 2013;32(5):629-33. [https://doi.org/10.1007/s10067-012-2154-6] [PMID: 23318705]
  57. Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, et al. Vitamin D: a negative acute phase reactant. Clin Pathol 2013;66(7):620-2. [https://doi.org/10.1136/jclinpath-2012-201301] [PMID: 23454726]
  58. Heidari B. Rheumatoid Arthritis: Early diagnosis and treatment outcomes. Caspian J Intern Med 2011;2(1):161-70. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766928/] [PMID: 24024009]
  59. Walsh DA, McWilliams DF. Pain in rheumatoid arthritis. Curr Pain Headache Rep 2012;16(6):509-17. [https://doi.org/10.1007/s11916-012-0303-x] [PMID: 23109051]
  60. Heidari B, Heidari P, Tilaki KH. Relationship between unexplained arthralgia and vitamin D deficiency: a case control study. Acta Med Iran 2014;52(5):400-5. [PMID: 24902022]
  61. Heidari B, Javadian Y, Babaei M, Yousef-Ghaheri B. Restorative effect of vitamin D deficiency on knee pain and quadriceps muscle strength in knee osteoarthritis. Acta Med Iran 2015;53:466-70. [PMID: 26545990]
  62. Armstrong C, Swarbrick CM, Pye SR, O'Neill TW. Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis 2005;64(11):1602-4. [https://doi.org/10.1136/ard.2004.031195] [PMID: 15817660] [PMCID: PMC1755283]
  63. Gendelman O, Itzhaki D, Makarov S, Bennun M, Amital H. A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain. Lupus 2015;24(4-5):483-9. [https://doi.org/10.1177/0961203314558676] [PMID: 25801891]
  64. Buondonno I, Rovera G, Sassi F, Rigoni MM, Lomater C, Parisi S, et al. Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study. PLoS One 2017;12(6):e0178463. [https://doi.org/10.1371/journal.pone.0178463] [PMID: 28582403] [PMCID: PMC5459341]
  65. Salesi M, Farajzadegan Z. Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatol Int 2012;32(7):2129-33. [https://doi.org/10.1007/s00296-011-1944-5]
  66. Yang J, Liu L, Zhang Q, Li M, Wang J. Effect of vitamin D on the recurrence rate of rheumatoid arthritis. Exp Ther Med 2015;10(5):1812-6. [https://doi.org/10.3892/etm.2015.2747] [PMID: 26640554] [PMCID: PMC4665932]
  67. Dehghan A, Rahimpour S, Soleymani-Salehabadi H, Owlia MB. Role of vitamin D in flare ups of rheumatoid arthritis. Z Rheumatol 2014;73(5):461-4. [https://doi.org/10.1007/s00393-013-1297-4] [PMID: 24352479]
  68. Andjelkovic Z, Vojinovic J, Pejnovic N, Popovic M, Dujic A, Mitrovic D, et al. Disease modifying and immunomodulatory effects of high dose 1 a (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999;17(4):453-6. [PMID: 10464556]
  69. Chandrashekara S, Patted A. Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study. Int J Rheum Dis 2017;20(7):825-31. [https://doi.org/10.1111/1756-185X.12770]
  70. Lourdudoss C, Wolk A, Nise L, Alfredsson L, Vollenhoven RV. Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study. BMJ Open 2017;7(6):e016154. [https://doi.org/10.1136/bmjopen-2017-016154] [PMID: 28601838] [PMCID: PMC5541601]
  71. Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 2011;40(6):512-31.e8. [https://doi.org/10.1016/j.semarthrit.2010.07.009] [PMID: 21047669] [PMCID: PMC3098920]